2-[4-[[2,6-bis[4-(trifluoromethyl)phenyl]-4-pyridinyl]methylsulfanyl]-2-methylphenoxy]acetic acid
C29H21F6NO3S — CID 88941524
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[4-[[2,6-bis[4-(trifluoromethyl)phenyl]-4-pyridinyl]methylsulfanyl]-2-methylphenoxy]acetic acid
2-[4-[[2,6-bis[4-(trifluoromethyl)phenyl]-4-pyridinyl]methylsulfanyl]-2-methylphenoxy]acetic acid (PubChem CID 88941524) has the molecular formula C29H21F6NO3S and a molecular weight of 577.55 g/mol. Its IUPAC name is 2-[4-[[2,6-bis[4-(trifluoromethyl)phenyl]-4-pyridinyl]methylsulfanyl]-2-methylphenoxy]acetic acid.
Molecular Properties
| Compound Name | 2-[4-[[2,6-bis[4-(trifluoromethyl)phenyl]-4-pyridinyl]methylsulfanyl]-2-methylphenoxy]acetic acid |
|---|---|
| PubChem CID | 88941524 |
| Molecular Formula | C29H21F6NO3S |
| Molecular Weight | 577.55 g/mol |
| Exact Mass | 577.11 |
| IUPAC Name | 2-[4-[[2,6-bis[4-(trifluoromethyl)phenyl]-4-pyridinyl]methylsulfanyl]-2-methylphenoxy]acetic acid |
| SMILES | Cc1cc(SCc2cc(-c3ccc(C(F)(F)F)cc3)nc(-c3ccc(C(F)(F)F)cc3)c2)ccc1OCC(=O)O |
| InChI | InChI=1S/C29H21F6NO3S/c1-17-12-23(10-11-26(17)39-15-27(37)38)40-16-18-13-24(19-2-6-21(7-3-19)28(30,31)32)36-25(14-18)20-4-8-22(9-5-20)29(33,34)35/h2-14H,15-16H2,1H3,(H,37,38) |
| InChIKey | XDVJUXJNUJQNTN-UHFFFAOYSA-N |
| XLogP | 8.52 |
| TPSA | 59.42 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 40 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 577.55 |
| LogP ≤ 5 | 8.52 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 88941524 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.